Support program for genetic testing in advanced cancer
Part of Blood & lymphatic, Cancer, Digestive system clinical trials.
This trial looks at whether a special support program can help increase participation in cancer genetic testing for patients with advanced cancer. The goal is to help you understand your cancer better and see if genetic testing could lead to more treatment options for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have cancer that is advanced or has spread, and need active treatment (not just monitoring).
- You must be a patient at one of the participating Dana-Farber locations: Longwood/Chestnut Hill, BMC-Brighton (formerly St. Elizabeth's), Foxborough, or Merrimack Valley.
- You must be able to speak English, Spanish, Haitian Creole, Russian, Portuguese, Arabic, or Traditional Chinese.
- You must be able to give consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects and analyzes genetic information from tissue or blood samples to help understand cancer and related inherited (family) risk. It may involve testing results being shared with you or your care team, depending on what samples are available.
This study tests whether a special program led by oncology nurses can help more people with solid tumor cancers get genetic testing. If you are starting a new treatment and have not had genetic testing before, this program may help you learn about your cancer risks and treatment options.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This study offers free genetic testing to cancer patients and their healthcare providers. It aims to help people who may not have easy access to genetic testing understand their cancer risk.
This study uses genetic testing of your tumor to find specific mutations and match you with targeted therapies, aiming to improve outcomes for advanced cancers with poor prognosis. If you have pancreatic, liver, or triple negative breast cancer and are starting treatment, this trial may help you access personalized treatment options.
This trial investigates genetic testing (mutational profiling) in people with various advanced cancers. It aims to understand how these tests can guide more personalized treatment decisions.
Hear when a new Gastrointestinal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.